title: Oral or vaginal misoprostol administration for induction of labor: a randomized, double-blind trial.
abstract: OBJECTIVE
  To compare the efficacy and vaginal birth intervals after intravaginal or oral misoprostol for labor induction.
  
  
  METHODS
  One hundred seventy-eight women were randomized to one of two double-blind groups: 1) oral misoprostol 200 microg and one-half tablet placebo intravaginal or 2) oral placebo tablet and one-half tablet of a 100-microg misoprostol intravaginal (dose 50 microg). Doses were repeated every 6 hours until labor was established (maximum of three doses).
  
  
  RESULTS
  Ninety-three subjects were assigned to oral misoprostol and 85 to intravaginal administration. Oral administration was accompanied by significantly shorter intervals to the onset of uterine contractility (133+/-78 minutes versus 168+/-93, P < .01) but a higher incidence of abnormal uterine contractile activity (tachysystole 38.7% versus 20.0%, P < .01; hyperstimulation syndrome 44.1% versus 21.2%, P < .01). No adverse maternal or neonatal outcomes were noted, nor were there differences in cesarean delivery rates or total lengths of labor.
  
  
  CONCLUSIONS
  Oral administration of 200 microg misoprostol has similar efficacy to intravaginal administration of 50 microg but is associated with more frequent abnormal uterine contractility.
authors.affiliation: Department of Obstetrics and Gynecology, Louisiana State University School of Medicine-Shreveport, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Adair
authors.forename: J W
authors.initials: JW
authors.lastname: Weeks
authors.forename: S
authors.initials: S
authors.lastname: Barrilleaux
authors.forename: M
authors.initials: M
authors.lastname: Edwards
authors.forename: K
authors.initials: K
authors.lastname: Burlison
authors.forename: D F
authors.initials: DF
authors.lastname: Lewis
mesh_terms: D000282:Administration, Intravaginal; D000284:Administration, Oral; D000328:Adult; D036861:Delivery, Obstetric / Q000379:methods; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D014590:Uterine Contraction / Q000187:drug effects
chemical_list: D016595:Misoprostol